SCHEMBL4083893

SCHEMBL4083893

Cc1c(C(=O)C(=O)NC2CCCCC2)c2cc(Cl)ccc2n1Cc1ccc(Cl)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CNR2 P34972 6/20 0.50
MAPT P10636 3/20 0.50
FAAH O00519 2/20 0.50
POLB P06746 1/20 0.46
CNR1 P21554 2/20 0.45
PPARG P37231 1/20 0.45
GAA P10253 2/20 0.44
EPHX1 P07099 1/20 0.44
TP53 P04637 1/20 0.44
RAB9A P51151 1/20 0.44
ALDH1A1 P00352 2/20 0.43
PKM P14618 2/20 0.43
MEN1 O00255 1/20 0.43
RGS12 O14924 1/20 0.43
LMNA P02545 1/20 0.43
CYP1A2 P05177 1/20 0.43
CYP3A4 P08684 1/20 0.43
CYP2C9 P11712 1/20 0.43
TSHR P16473 1/20 0.43
NFKB1 P19838 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4083374 0.95 FAAH (0.52) CNR2MAPTFAAHGAAALDH1A1
SCHEMBL2992971 0.94 FAAH (0.57) CNR2MAPTFAAHPOLBCNR1
SCHEMBL2991276 0.91 ALDH1A1 (0.57) CNR2MAPTFAAHALDH1A1PKM
SCHEMBL4094014 0.90 TP53 (0.52) CNR2MAPTFAAHPOLBPPARG
SCHEMBL3010200 0.90 POLB (0.48) CNR2MAPTPOLBCNR1GAA
SCHEMBL2998737 0.89 POLB (0.46) CNR2MAPTFAAHPOLBCNR1
SCHEMBL3005561 0.86 CNR2 (0.43) CNR2MAPTFAAHPOLBCNR1
SCHEMBL3005273 0.86 FAAH (0.49) CNR2FAAHPOLBCNR1EPHX1
SCHEMBL4083920 0.85 ALDH1A1 (0.60) MAPTFAAHALDH1A1PKMMEN1
SCHEMBL3008931 0.85 POLB (0.44) CNR2FAAHPOLBCNR1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090118503-A1 FAAH INHIBITORS IRONWOOD PHARMACEUTICALS, INC. 2009-05-07 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090118503-A1 FAAH INHIBITORS FAAH, FAAH2, CNR2 CNR2 3/4885MAPT 2737/4885FAAH 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.